The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 multicenter trial to assess the maximum tolerated dose, safety, pharmacokinetics, and pharmacodynamics of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma.
 
Kieuhoa Tran Vo
No Relationships to Disclose
 
Jennifer Gibney Michlitsch
No Relationships to Disclose
 
Avanthi T Shah
No Relationships to Disclose
 
Janel Long-Boyle
No Relationships to Disclose
 
Mi-Ok Kim
No Relationships to Disclose
 
Clay Gustafson
No Relationships to Disclose
 
Alejandro Sweet-Cordero
No Relationships to Disclose
 
Katherine K. Matthay
No Relationships to Disclose
 
Steven G. DuBois
Honoraria - Loxo
Consulting or Advisory Role - Loxo
Research Funding - Curis (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Loxo; Roche/Genentech